TrialDiabetes care2008

Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome.

Esther M M Ooi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.